Company profile
CyGenica Ltd.
Enabling SAFE, targeted and affordable intracellular delivery of therapeutics for cancer and rare diseases.
- Industry
- Research
- Employees
- 10
- Headquarters
- Cork, Cork
- Founded
- 2017
- LinkedIn followers
- 3,754
- Office locations
- 2
CyGenica Ltd. company summary
CyGenica Ltd. is a company in the Research industry, headquartered in Cork, Cork, founded in 2017. On LinkedIn the company has around 10 employees and 3,754 followers. The company lists 2 office locations. Its listed specialties include Biotechnology, Drug delivery system, Cancer, Pharmaceutical Industry, Lab Reagents.
What technology does CyGenica Ltd. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About CyGenica Ltd.
What We Do CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics. The most crucial issue of intracellular delivery for large molecules, especially for gene therapy, remains the cellular membrane. This biological barrier is a double-edged sword; while it prevents infectious agents from entering our body and causing disease, it also stands between the successful use of life-saving medicines and advanced therapeutic technologies. The successful delivery of therapeutics into target cells and organelles would minimize the undesired ‘off target’ side effects and reduce the required dose. Why We Do Our founder’s father was diagnosed with cancer when she was still a student. She witnessed her father suffering from the side effects of his therapy over years. This life experience defined the goal of her life 'how to make cancer drugs safer and better' to make an impact in oncology and do her bit in the global fight against cancer. CyGenica is the result of her and our team’s intense desire to make significant contributions to alleviate this suffering and improve the quality of life of millions of cancer patients. Who We Are We are a team of ambitious academicians and professionals striving to improve patient outcomes worldwide. Our goal is to develop the world's safest molecular carrier for therapeutics delivery and grow as an authentic market leader in enabling the next generation genome editing therapeutics for various life-threatening diseases such as cancer. With an indomitable spirit, we are committed to improve the quality of life of such patients.
Specialties
Where is CyGenica Ltd. located?
CyGenica Ltd. lists 2 office locations.
Compare companies similar to CyGenica Ltd.
More companies in Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
CyGenica Ltd. cygenica.com | Research | 10 | 2017 | Cork, Cork |
| Research | 4,823 | 1945 | Pretoria, Gauteng | |
 X, The Moonshot Factory x.company | Research | 3,088 | - | Mountain View, CA |
 CSIC csic.es | Research | 5,795 | 1939 | Madrid, Comunidad de Madrid |
 icddr,b icddrb.org | Research | 3,180 | 1960 | Dhaka , Dhaka |
 Abdul Latif Jameel Poverty Action Lab (J-PAL) povertyactionlab.org | Research | 760 | 2003 | Cambridge, MA |
 BRIC-National Institute of Immunology nii.res.in | Research | 237 | 1986 | New Delhi, Delhi |
| Research | 181 | - | Wageningen, Gelderland | |
| Research | 171 | 2017 | Bengaluru, Karnataka | |
 CIAT alliancebioversityciat.org | Research | 1,343 | 1967 | Cali, Valle del Cauca |
 Stockholm Resilience Centre stockholmresilience.org | Research | 191 | 2007 | Stockholm, Stockholm |
Frequently asked questions about CyGenica Ltd.
What does CyGenica Ltd. do?
What We Do CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics. The most crucial issue of intracellular delivery for large molecules, especially for gene therapy, remains the cellular membrane. This biological barrier is a double-edged sword; while it prevents infectious agents from entering our body and causing disease, it also stands between the successful use of life-saving medicines and advanced therapeutic technologies. The successful delivery of therapeutics into target cells and organelles would minimize the undesired ‘off target’ side effects and reduce the required dose. Why We Do Our founder’s father was diagnosed with cancer when she was still a student. She witnessed her father suffering from the side effects of his therapy over years. This life experience defined the goal of her life 'how to make cancer drugs safer and better' to make an impact in oncology and do her bit in the global fight against cancer. CyGenica is the result of her and our team’s intense desire to make significant contributions to alleviate this suffering and improve the quality of life of millions of cancer patients. Who We Are We are a team of ambitious academicians and professionals striving to improve patient outcomes worldwide. Our goal is to develop the world's safest molecular carrier for therapeutics delivery and grow as an authentic market leader in enabling the next generation genome editing therapeutics for various life-threatening diseases such as cancer. With an indomitable spirit, we are committed to improve the quality of life of such patients.
How many employees does CyGenica Ltd. have?
CyGenica Ltd. has around 10 employees on LinkedIn.
Where is CyGenica Ltd. headquartered?
CyGenica Ltd. is headquartered in Cork, Cork.
Where does CyGenica Ltd. have offices?
CyGenica Ltd. lists 2 office locations, including Cork, Cork T12 P928, IE; Pashan, Pune, Maharashtra 411008.
When was CyGenica Ltd. founded?
CyGenica Ltd. was founded in 2017.
Build a lead list from companies like CyGenica Ltd.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.